Has your doctor prescribed acid reflux disease medicine? If so, there are several things that you should know about before you continue taking acid reflux medicines. In a short article, I'll be going over some of those things to be careful about and hopefully by the time you finish reading this you have a better idea of what to look out for.
One of the biggest dangers of taking acid reflux medicines, is the fact that people begin to rely on them. Acid reflux medicine really only masks symptoms, it doesn't get to the root of the problem. Instead of using prescription medicine as a crutch, it's important to learn how to treat the underlying condition.
In many cases, what he can greatly affect your acid reflux condition. Simply avoiding foods that have high acidic content will help treat the root of the problem and prevent flareups.
There are many foods that you should avoid in this case, some of these include citrus fruits, red meat, yogurt, foods that are fried or fatty, etc.
Instead of eating these foods, replace them with foods that are high in fiber and high in protein. Often times, simply monitoring and making changes to your diet can be far more good than acid reflux medicine.
Vonseca® is the first full range Generic of Vonoprazan In Egypt
As per its commitment to offer the latest treatment for the Egyptian's patients., in Jan 2022 Zeta Pharma was the first Egyptian pharmaceutical company to introduce two concentrations of 10mg and 20 mg of vonoprazan in the Egyptian market through its brand Vonseca.®
? is a first-in-class potassium-competitive acid blocker. It was approved in the Japanese market in February 2015.
Vonoprazan is used in form of the fumarate for the treatment of gastroduodenal ulcer (including some drug-induced peptic ulcers) and reflux esophagitis, and can be combined with antibiotics for the eradication of Helicobacter pylori.
The (?) has approved 2 ?-based medications for the treatment of Helicobacter pylori (H. pylori) infection.
The approval of ? treatment regimens offers physicians and patients 2 therapeutic options that showed superior eradication rates compared to proton pump inhibitor-based (PPI) lansoprazole triple therapy in the overall patient population in a pivotal trial.
? belongs to a class of products known as PCAB, or potassium-competitive acid blockers. By blocking the potassium-binding site of gastric hydrogen potassium ATPase (also known as the proton pump), which is the enzyme largely responsible for acidification of the stomach, it’s designed to overcome many of the perceived weaknesses of traditional proton pump inhibitor therapy.
If you need any kind of information on this article related topic click here: Vonoprazan
Comments